- Author:
Wilmar M WIERSINGA
1
Author Information
- Publication Type:Review
- Keywords: Graves hyperthyroidism; Cure; Thyroidectomy; Radioactive iodine; Antithyroid agents; Remission; Long term outcome
- MeSH: Antibodies; Antibodies, Blocking; Antithyroid Agents; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodide Peroxidase; Receptors, Thyrotropin; Recurrence; Reference Values; Thyroid Gland; Thyroidectomy; Thyrotropin; Thyroxine; Triiodothyronine
- From:Endocrinology and Metabolism 2019;34(1):29-38
- CountryRepublic of Korea
- Language:English
- Abstract: Whether or not Graves' hyperthyroidism can be really cured, depends on the definition of “cure.” If eradication of thyroid hormone excess suffices for the label “cure,” then all patients can be cured because total thyroidectomy or high doses of 1¹³¹I will abolish hyperthyroidism albeit at the expense of creating another disease (hypothyroidism) requiring lifelong medication with levothyroxine. I would not call this a “cure,” which I would like to define as a state with stable thyroid stimulating hormone (TSH), free thyroxine, and triiodothyronine serum concentrations in the normal range in the absence of any thyroid medication. Surgery and radioiodine are unlikely to result in so-defined cures, as their preferable aim as stated in guidelines is to cause permanent hypothyroidism. Discontinuation of antithyroid drugs is followed by 50% recurrences within 4 years; before starting therapy the risk of recurrences can be estimated with the Graves' Recurrent Events After Therapy (GREAT) score. At 20-year follow-up about 62% had developed recurrent hyperthyroidism, 8% had subclinical hypothyroidism, and 3% overt hypothyroidism related to TSH receptor blocking antibodies and thyroid peroxidase antibodies. Only 27% was in remission, and might be considered cured. If the definition of “cure” would also include the disappearance of thyroid antibodies in serum, the proportion of cured patients would become even lower.